首页|期刊导航|iLIVER|Debates and progress in the management of intermediate-stage(BCLC stage B)hepatocellular carcinoma

Debates and progress in the management of intermediate-stage(BCLC stage B)hepatocellular carcinoma

Jianan Jiang Yinbiao Cao Shang Gao Yanqin Hu Shizhong Yang Haowen Tang

iLIVER2025，Vol.4Issue(3)：P.169-181,13.

iLIVER2025，Vol.4Issue(3)：P.169-181,13.DOI:10.1016/j.iliver.2025.100187

Debates and progress in the management of intermediate-stage(BCLC stage B)hepatocellular carcinoma

Jianan Jiang ¹Yinbiao Cao ²Shang Gao ³Yanqin Hu ³Shizhong Yang ⁴Haowen Tang³

作者信息

1. School of Medicine,Tsinghua University,Beijing 100084,China
2. Faculty of Hepato-Pancreato-Biliary Surgery,the First Medical Center of Chinese PLA General Hospital,Beijing 100853,China
3. Faculty of Hepato-Pancreato-Biliary Surgery,the First Medical Center of Chinese PLA General Hospital,Beijing 100853,China School of Medicine,Nankai University,Tanjin 300071,China
4. Hepato-pancreato-biliary Center,Beijing Tsinghua Changgung Hospital,Beijing 102218,China
折叠

摘要

关键词

Intermediate-stage hepatocellular carcinoma/Heterogeneity/TACE/Precise treatment

分类

医药卫生

引用本文复制引用

Jianan Jiang,Yinbiao Cao,Shang Gao,Yanqin Hu,Shizhong Yang,Haowen Tang..Debates and progress in the management of intermediate-stage(BCLC stage B)hepatocellular carcinoma[J].iLIVER,2025,4(3):P.169-181,13.

基金项目

supported by Beijing Natural Science Foundation,China(L244027). （L244027）

iLIVER

ISSN：2772-9478

访问量1

下载量0

段落导航